EAM Investors’s MacroGenics MGNX Stock Holding History

EAM Investors’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-128,176	Closed	-$4.02M	–	355
2015 Q1	$4.02M	Buy	128,176 +13,137	+11%	+$445K	0.46%	47
2014 Q4	$4.03M	Buy	+115,039	New	+$2.87M	0.56%	27
2014 Q2	–	Sell	-32,451	Closed	-$903K	–	346
2014 Q1	$903K	Buy	+32,451	New	+$1.15M	0.16%	303

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

EAM Investors's MGNX Position: Q2 2015 in Review

EAM Investors sold out of MacroGenics (MGNX) in Q2 2015, closing a stake of 128,176 shares — an estimated $4.02M sold.

EAM Investors first reported a position in MGNX in Q1 2014 and held it in 3 quarters. The position peaked at $4.03M in Q4 2014. 128 funds tracked by Wall St. Rank hold MGNX as of Q2 2015.

EAM Investors reported no remaining MacroGenics position as of Q2 2015 after selling out during the quarter.
EAM Investors sold 128,176 MacroGenics shares in Q2 2015, an estimated $4.02M.
EAM Investors first reported a position in MacroGenics in Q1 2014 and held it in 3 quarters.
EAM Investors's MacroGenics position peaked at $4.03M in Q4 2014.
128 funds tracked by Wall St. Rank held MacroGenics as of Q2 2015.

Based on EAM Investors's 13F filing for Q2 2015, filed 13 Aug 2015.